Economists clearly articulated last year that governments should buy capacity, not doses directly. Because that just pushes prices up (and we see the conflicts about fulfilling orders).
Furthermore. Since the process of vaccine development and manufacturing is closed, done in the shadows, no one had any idea where the bottleneck will be. (Yes, some companies bet on their vaccine and started expansion while the development was ongoing. And Derek speculates that the supply chain is at full capacity, but ... we don't know, and again, we could have been expanding that too exactly since a year ago.)
The mRNA LPN packaging might be new, but manufacturing plasmids that churn out Adeno Associated Virus particles with the correct payload is so old tech random youtube dude did it in 2018 February.
https://m.youtube.com/watch/J3FcbFqSoQY